Sagaliam Acquisition Corp.
SAGAU
NASDAQ Global Market11.27
USD
+0.24
- -
CIK
0001855351
ISIN
US78661R2058
CUSIP
78661R205
Return %
Stock
S&P500
1Y
6.82
26.84
3Y
13.04
77.03
5Y
13.04
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Barry J. Kostiner
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1800 Avenue of the Stars Los Angeles CA United States of America 90067
- IPO Date
- Dec 21, 2021
- CIK
- 0001855351
- Website
- sagaliam.com
- Similar Companies
- Business
- Sagaliam Acquisition Corp. (SAGAU) is a blank check company focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting opportunities in the telecommunications, media, technology, biotechnology, and pharmaceutical sectors; it offers no current operational products or services beyond its SPAC structure for facilitating such transactions. Incorporated in 2021 and headquartered in Los Angeles, California, the company operates principally in the United States with strategic interests in global markets including nutraceutical and therapeutic development platforms. In recent developments, Sagaliam entered into a Novation Agreement in April 2024 with Enzolytics, Inc., Biogenysis, Inc., and Virogentics, Inc., retaining 100% ownership of its Virogentics subsidiary and associated therapeutic and nutraceutical platforms such as the ITV-1 platform and improved IPF formulas with vitamin C in pill and lozenge forms alongside new slimming nutraceuticals; it executed a definitive business combination agreement valued at $450 million for acquiring Biogenysis and Virogentics operating subsidiaries, announced delisting of common shares from Nasdaq transitioning to OTC markets, received Nasdaq delisting notifications and compliance issues including a temporary restraining order on its extension proxy meeting, regained partial Nasdaq compliance under listing rule 5250(c)(1), and previously pursued but restructured a merger with Arabian Entertainment Company and an extension of its initial business combination deadline to January 2023 with Allenby Montefiore Limited.